Stay updated with breaking news from Tuberculosis Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55% and 33% price reduction, respectively.
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB,...
Most people at risk of Tuberculosis are from low- and middle-income countries who will not afford costly vaccines or drugs. The incentive for big pharma companies to invest in Tuberculosis vaccine development is low.
The Latest research study released by Absolute Markets Insights "Tuberculosis Drug Market" with 100+ pages of analysis on business Strategy taken up by key and
Tuberculosis Drug Market Report Coverage: Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast. Latest launched research on Global Tuberculosis Drug Market, it provides detailed analysis with presentable graphs, charts and tables. This report covers an in depth study of the Tuberculosis Drug Market size, growth, and share, trends, consumption, segments, application and Forecast 2027. With qualitative and quantitative analysis, we help you with t...